Aptevo Therapeutics (APVO) Institutional Ownership $0.41 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Aptevo Therapeutics (NASDAQ:APVO)CurrentInstitutional OwnershipPercentage8.06%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$37.30MNumber ofInstitutional Sellers(last 12 months)0 Get APVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Aptevo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data APVO Institutional Buying and Selling by Quarter Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE Aptevo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2023Sabby Management LLC1,334,169$440K0.3%N/A11.581% 11/15/2023Armistice Capital LLC1,235,000$408K0.0%N/A10.717% 2/1/2023Bank of Montreal Can10,000$61K0.0%N/A0.196% 11/15/2022Cantor Fitzgerald L. P.133,700$406K0.0%N/A2.627% 11/7/2022Virtu Financial LLC28,421$86K0.0%+122.6%0.558% 12/10/2021Towercrest Capital Management211,227$3.26M0.6%N/A4.313% Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/8/2021Moors & Cabot Inc.389,269$3.73M0.2%N/A7.948% 11/15/2021Franklin Resources Inc.15,650$242K0.0%N/A0.320% 11/15/2021GSA Capital Partners LLP13,651$211K0.0%N/A0.279% 11/12/2021Renaissance Technologies LLC143,419$2.21M0.0%-10.3%2.931% 11/9/2021BlackRock Inc.55,394$856K0.0%+1.9%1.133% 11/5/2021Moors & Cabot Inc.389,269$3.73M0.3%N/A7.954% 8/17/2021Balyasny Asset Management LLC18,012$404K0.0%-70.6%0.405% 8/17/2021Boothbay Fund Management LLC15,350$344K0.0%+4.9%0.345% 8/16/2021Alyeska Investment Group L.P.139,172$3.12M0.0%-80.9%3.127% 8/16/2021Morgan Stanley8,364$187K0.0%+163.4%0.188% 8/16/2021Kennedy Capital Management Inc.187,995$4.22M0.1%N/A4.225% 8/16/2021State Street Corp10,973$246K0.0%N/A0.247% 8/13/2021Renaissance Technologies LLC159,923$3.59M0.0%-23.6%3.594% 8/13/2021Anson Funds Management LP35,587$798K0.1%-26.6%0.800% 8/13/2021Northern Trust Corp22,652$508K0.0%+170.7%0.509% 8/13/2021QS Investors LLC15,650$352K0.0%+37.3%0.352% 8/13/2021Geode Capital Management LLC38,917$872K0.0%+8.8%0.875% 8/13/2021Vanguard Group Inc.134,760$3.02M0.0%+2.9%3.028% 5/17/2021Schonfeld Strategic Advisors LLC9,700$296K0.0%-12.6%0.218% 5/14/2021RTW Investments LP281,402$8.59M0.1%-2.4%6.324% 5/14/2021Dynamic Technology Lab Private Ltd14,022$428K0.0%+6.2%0.315% 5/13/2021QS Investors LLC11,400$348K0.0%N/A0.256% 5/13/2021JBF Capital Inc.3,907$119K0.0%+49.9%0.088% 5/13/2021Renaissance Technologies LLC209,223$6.39M0.0%-17.8%4.702% 5/13/2021Bank of New York Mellon Corp9,964$305K0.0%N/A0.224% 5/13/2021Bank of Montreal Can25,280$674K0.0%-20.1%0.568% 5/12/2021Geode Capital Management LLC35,762$1.09M0.0%+26.8%0.804% 5/7/2021BlackRock Inc.57,605$1.76M0.0%-1.0%1.294% 3/8/2021Dimensional Fund Advisors LP5,502$202K0.0%N/A0.126% 2/25/2021Dimensional Fund Advisors LP5,502$202K0.0%N/A0.126% 2/24/2021Alyeska Investment Group L.P.49,601$1.82M0.0%N/A1.133% 2/18/2021Ghost Tree Capital LLC50,000$1.83M0.4%N/A1.142% 2/16/2021Alyeska Investment Group L.P.49,601$1.82M0.0%N/A1.133% 2/16/2021Pura Vida Investments LLC8,203$301K0.0%N/A0.187% “Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. 2/16/2021Price T Rowe Associates Inc. MD6,300$231K0.0%N/A0.144% 2/12/2021Stonepine Capital Management LLC18,280$670K0.5%N/A0.417% 2/11/2021JBF Capital Inc.2,607$96K0.0%N/A0.060% 2/11/2021Northern Trust Corp8,707$319K0.0%N/A0.199% 2/11/2021Citigroup Inc.967$35K0.0%N/A0.022% 2/11/2021Dynamic Technology Lab Private Ltd13,202$484K0.1%N/A0.301% 2/10/2021Renaissance Technologies LLC254,423$9.33M0.0%-13.1%5.810% 2/9/2021Wells Fargo & Company MN1,552$57K0.0%+241.1%0.035% 2/5/2021BlackRock Inc.58,168$2.13M0.0%+166.8%1.328% 11/16/2020Worth Venture Partners LLC27,645$210K0.2%-21.8%0.667% 11/9/2020Acadian Asset Management LLC45,126$344K0.0%-2.5%1.396% 11/6/2020GSA Capital Partners LLP40,512$308K0.1%N/A1.253% 8/5/2020WINTON GROUP Ltd11,332$95K0.0%N/A0.351% 7/31/2020UBS Group AG10,015$83K0.0%-13.3%0.310% (Data available from 1/1/2016 forward) APVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of APVO shares? During the previous two years, the following institutional investors and hedge funds held shares of Aptevo Therapeutics shares: Sabby Management LLC ($440K), Armistice Capital LLC ($408K), Cantor Fitzgerald L. P. ($406K), and Virtu Financial LLC ($86K), Bank of Montreal Can ($61K).Learn more on APVO's institutional investors. What percentage of Aptevo Therapeutics stock is owned by institutional investors? 8.06% of Aptevo Therapeutics stock is owned by institutional investors. Learn more on APVO's institutional investor holdings. Which institutional investors have been buying Aptevo Therapeutics stock? The following institutional investors have purchased Aptevo Therapeutics stock in the last 24 months: Sabby Management LLC ($1.33M), Armistice Capital LLC ($1.24M), Cantor Fitzgerald L. P. ($133.70K), Virtu Financial LLC ($15.65K), and Bank of Montreal Can ($10K). How much institutional buying is happening at Aptevo Therapeutics? Institutional investors have bought a total of 2,728,522 shares in the last 24 months. This purchase volume represents approximately $58.30M in transactions. Related Companies: MBIO Major Shareholders OGEN Major Shareholders PCSA Major Shareholders ADIL Major Shareholders VIRI Major Shareholders TRVN Major Shareholders GNPX Major Shareholders ENVB Major Shareholders CLVR Major Shareholders GTBP Major Shareholders This page (NASDAQ:APVO) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.